2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4- methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists

Hyungchul Ryu, Sejin Seo, Myeong Seop Kim, Mi Yeon Kim, Ho Shin Kim, Jihyae Ann, Phuong Thao Tran, Van Hai Hoang, Jieun Byun, Minghua Cui, Karam Son, Pankaz Kumar Sharma, Sun Choi, Peter M. Blumberg, Robert Frank-Foltyn, Gregor Bahrenberg, Babette Yvonne Koegel, Thomas Christoph, Sven Frormann, Jeewoo Lee

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

A series of 2-aryl pyridine C-region derivatives of 2-(3-fluoro-4- methylsulfonylaminophenyl)propanamides were investigated as hTRPV1 antagonists. Multiple compounds showed highly potent TRPV1 antagonism toward capsaicin comparable to previous lead 7. Among them, compound 9 demonstrated anti-allodynia in a mouse neuropathic pain model and blocked capsaicin-induced hypothermia in a dose-dependent manner. Docking analysis of 9 with our hTRPV1 homology model provided insight into its specific binding mode.

Original languageEnglish
Pages (from-to)4044-4047
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number16
DOIs
StatePublished - 15 Aug 2014

Bibliographical note

Funding Information:
We greatly acknowledge Elke Schumacher and Franz-Josef Butz for technical assistance in CCI and Cap hypothermia studies, resp. This research was supported by Research Grants from Grunenthal , Germany, Grants from the National Research Foundation of Korea (NRF) (R11-2007-107-02001-0), Grants from the National Leading Research Lab (NLRL) program (2011-0028885), Republic of Korea, and in part by the Intramural Research Program of NIH, Center for Cancer Research, NCI (Project Z1A BC 005270), USA.

Keywords

  • Capsaicin
  • Molecular modeling
  • Resiniferatoxin
  • TRPV1 antagonist
  • Vanilloid receptor 1

Fingerprint

Dive into the research topics of '2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4- methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists'. Together they form a unique fingerprint.

Cite this